Pierre Lavaud, MD

Department of Psychiatry, AP-HP, Hôpital Corentin-Celton, Issy-les-Moulineaux, France

JCP
Prevalence and 3-Year Outcomes of Mood Disorders
Original Research

November 12, 2025

Lower relapse rates of secondary mood disorders at 3 years suggest a more favorable course when the underlying cause is identified and treated.
, , , et al
PCC
Letter to the Editor

August 15, 2014

, , , et al
JCP
Article

March 15, 2013

Read a full article on the generalizability in bipolar treatment and how they should carefully consider the impact of eligibility criteria.
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe